Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes. (Q54295290)

27 May 2018

title

Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes. (English)

1 reference

27 May 2018

0 references

4

1 reference

27 May 2018

Rhian Touyz

14

1 reference

27 May 2018

author name string

Mona Sedeek

1

1 reference

27 May 2018

Alex Gutsol

2

1 reference

27 May 2018

Augusto C Montezano

3

1 reference

27 May 2018

Aurelie Nguyen Dinh Cat

5

1 reference

27 May 2018

Chris R J Kennedy

6

1 reference

27 May 2018

Kevin D Burns

7

1 reference

27 May 2018

Mark E Cooper

8

1 reference

27 May 2018

Karin Jandeleit-Dahm

9

1 reference

27 May 2018

Patrick Page

10

1 reference

27 May 2018

Cedric Szyndralewiez

11

1 reference

27 May 2018

Freddy Heitz

12

1 reference

27 May 2018

Richard L Hebert

13

1 reference

27 May 2018

language of work or name

English

0 references

publication date

1 February 2013

1 reference

27 May 2018

published in

Clinical Science

1 reference

27 May 2018

volume

124

1 reference

27 May 2018

issue

3

1 reference

27 May 2018

page(s)

191-202

1 reference

27 May 2018

End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions

cites work

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Diabetic kidney disease with and without albuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Role of inflammation in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

The proximal tubule in the pathophysiology of the diabetic kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Diabetic nephropathy: important pathophysiologic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Oxidative stress as a major culprit in kidney disease in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Oxidative stress, diabetes, and diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

AGE, RAGE, and ROS in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Oxidants in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Nrf2 activators as attractive therapeutics for diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Clinical and experimental evidence for oxidative stress as an exacerbating factor of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Oxidative stress parameters as possible urine markers in patients with diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Bardoxolone methyl and kidney function in CKD with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Oxidases and peroxidases in cardiovascular and lung disease: new concepts in reactive oxygen species signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Oxidative stress and diabetic cardiovascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Effects of NADPH oxidase inhibitor in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Reactive oxygen species and vascular biology: implications in human hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

NADPH oxidases in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

A novel superoxide-producing NAD(P)H oxidase in kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Inhibition of mitogen-activated protein/extracellular signal-regulated kinase improves endothelial function and attenuates Ang II-induced contractility of mesenteric resistance arteries from spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Pathologic classification of diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Measurement of reactive oxygen species in cardiovascular studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Assessment of superoxide production and NADPH oxidase activity by HPLC analysis of dihydroethidium oxidation products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Normalizing NADPH oxidase contributes to attenuating diabetic nephropathy by the dual endothelin receptor antagonist CPU0213 in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Suppressing renal NADPH oxidase to treat diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Inhibition of renal gluconeogenesis contributes to hypoglycaemic action of NADPH oxidase inhibitor, apocynin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Mouse models of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Regulation of NADPH oxidase activity is associated with miRNA-25-mediated NOX4 expression in experimental diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Diabetes complications: the microRNA perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Hyperglycemia and the pathobiology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Nox4-derived reactive oxygen species mediate cardiomyocyte injury in early type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Subcellular localization of Nox4 and regulation in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Differential effects of diabetes on the expression of the gp91phox homologues nox1 and nox4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Association of genetic variants in the promoter region of genes encoding p22phox (CYBA) and glutamate cysteine ligase catalytic subunit (GCLC) and renal disease in patients with type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Mesenteric resistance arteries in type 2 diabetic db/db mice undergo outward remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

NOX family NADPH oxidases in liver and in pancreatic islets: a role in the metabolic syndrome and diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Molecular mechanisms of hypertension: role of Nox family NADPH oxidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Attenuation of renal injury in db/db mice overexpressing superoxide dismutase: evidence for reduced superoxide-nitric oxide interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Increased recruitment but impaired function of leukocytes during inflammation in mouse models of type 1 and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

Mitogen activated protein kinases in renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

LOX-1 and inflammation: a new mechanism for renal injury in obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120330

21 January 2018

Identifiers

DOI

10.1042/CS20120330

1 reference

27 May 2018

PubMed ID

22920224

1 reference

27 May 2018